Loading...
ROCO
4735
Market cap45mUSD
Oct 08, Last price  
38.05TWD
1D
0.13%
1Q
23.14%
Jan 2017
6.88%
IPO
113.76%
Name

Avita Corp

Chart & performance

D1W1MN
ROCO:4735 chart
P/E
15.72
P/S
1.56
EPS
2.42
Div yield, %
6.06%
Shrs. gr., 5y
1.32%
Rev. gr., 5y
-18.47%
Revenues
936m
+0.98%
1,247,590,0002,600,124,0002,325,162,0001,200,917,000879,080,000927,297,000936,386,000
Net income
93m
+61.01%
130,946,000520,070,000315,473,000101,128,00042,716,00057,876,00093,189,000
CFO
64m
-66.52%
0406,311,000237,007,000490,499,000212,022,000192,519,00064,459,000
Dividend
Aug 31, 20261.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

AViTA Corporation, established in 1996, is headquartered in New Taipei City, Taiwan. The company focuses on the creation and distribution of consumer medical devices for in-home use. Its extensive portfolio encompasses various personal healthcare gadgets, such as contact-free and infrared thermometers (designed for both ear and forehead), a selection of blood pressure monitors (available in arm, wrist, and innovative tubeless arm models), electronic lice removal combs, nasal aspirators, pulse oximeters, and nebulizers.

Key people

Zhongjie Zhuang
Chief Financial Officer, Corporate Governance Officer · since 2023
Qiang Ji
Vice Chairman of the Board, General Manager · since 2023
Xing Ouyang
Chief Technology Officer, Senior Deputy General Manager · since 2009
Qiugui Chen
Head of Accounting · since 2024
Lianrong Huang
Director · since 2007
Chaoming Liu
Director · since 2007
Zhengsong Zhuang
Director · since 2021
Minghui Zhuang
Chairman of the Board · since 2003
Yiling Zhuang
Director · since 2024
Futian Jiang
Independent Director · since 2016
Wenzheng Lin
Independent Director · since 2019
Shengchang Zhan
Independent Director · since 2021
URL
https://www.avita.com.tw/en/index/
IPO date
Apr 27, 2010
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT